SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-13-065190
Filing Date
2013-12-02
Accepted
2013-12-02 21:47:48
Documents
2
Period of Report
2013-11-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v362014_3.html 3  
1 OWNERSHIP DOCUMENT v362014_3.xml 3 2965
2 EXHIBIT 24 v362014_ex24.htm EX-24 10428
  Complete submission text file 0001144204-13-065190.txt   15018
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Issuer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CAPRICOR THERAPEUTICS, INC. 8840 WILSHIRE BLVD. 2ND FLOOR BEVERLY HILLS CA 90211
Business Address
Hamer Andrew Warwick (Reporting) CIK: 0001593254 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34058 | Film No.: 131253046